Effect of tolvaptan in a patient with autosomal dominant polycystic kidney disease after living donor liver transplantation
Kiyotaka Uchiyama(Japanese Red Cross Medical Center), Yoshitaka Ishibashi(Japanese Red Cross Medical Center), Mineo Nakatsuka(Japanese Red Cross Medical Center), Yuka Kamijo(Japanese Red Cross Medical Center), Kazuya Honda(Japanese Red Cross Medical Center), Mai Yanagi(Japanese Red Cross Medical Center), Ryochi Yoshida(Japanese Red Cross Medical Center)
Cited by 5
Related Papers
Anatomic Variations and Technical Problems of the Anterolateral Thigh Flap: A Report of 74 Cases
|Plastic & Reconstructive Surgery|1998|493
Anterolateral Thigh Flap Donor-Site Complications and Morbidity
|Plastic & Reconstructive Surgery|2000|261
Anterolateral Thigh Flap Donor-Site Complications and Morbidity
|Plastic & Reconstructive Surgery|2000|252
Versatility of the Free Anterolateral Thigh Flap for Reconstruction of Head and Neck Defects
|Archives of Otolaryngology - Head and Neck Surgery|1997|195
β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects
|Kidney International|2019|144